PHH (ir.parkha.cn) נכסי החברה

Park Ha Biological Technology (PHH) is a Chinese biotech holding company developing innovative longevity products derived from flora. This chart of total asset value, which currently stands at 3.99, serves as a valuation tool and demonstrates the scale of the business. The company minimizes its reliance on local demand for plant-based cosmetics through e-commerce while simultaneously expanding capacity to supply specialized raw materials to the agricultural and industrial sectors of the PRC.

The stability of Park Ha Biological Technology (PHH) relies on its material base for premium-segment hemp processing, where resource volume determines production potential. This metric, reverse-calculated via ROA, consolidates liabilities and equity, allowing investors to assess the actual maturity of the business through the dynamics of total assets. By analyzing the organization's asset valuation, one can identify the balance between financial stability and capital efficiency.